Quezon City.  The EcoWaste Coalition and the Consumer Rights to Safe Food (CRSF) appealed to the Food and Drug Administration ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...

Smoking is the primary driver of tobacco-related deaths and is highly restricted in most Swedish public places.

Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, today announced ...

When the stencil is removed, a metal patch remains on the particle. The particles, invisible to the naked eye, can be made in ...

AI Software fda large language model FDA claims victory with "Elsa" AI tool launch, but insiders call it half-baked Employees say FDA's Elsa launch prioritized optics over usability By Cal Jeffrey ...

The FDA first approved mifepristone about a quarter of a century ago, and it's proven to be safe and effective. So why is the FDA reviewing it again?

FDA Approves Liquidia Corporation (NASDAQ:LQDA)’s YUTREPIA for PAH, PH-ILD Amid Patent Dispute with United Therapeutics ...

Key takeaways: Liquidia Corporation received final FDA approval for Yutrepia for the treatment of PAH and PH-ILD. The company received tentative approval last year.

Today, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) announced a new, joint innovative research initiative that will serve as a key element in fulfilling ...

The FDA has freed Amgen’s mysterious early-stage obesity asset from a clinical hold, with the phase 1 study now enrolling participants.